Glaukos Corporation

NYSE:GKOS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🩺 Medical Instruments

💊 Pharmaceuticals

Location

United States

Market Cap

USD 5.12 B

Share Price

USD 89.34

Avg Daily Volume

992,250

Change (1 day)

2.67%

Change (1 year)

-26.46%

Change (YTD)

-40.42%

Glaukos Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 36.05 M

Glaukos Corporation Depreciation And Amortization is USD 36.05 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -6.66% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.

Glaukos Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 38.62 M, a 6.08% change year over year.
Glaukos Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 36.41 M, a 4.76% change year over year.
Glaukos Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 34.75 M, a 0.62% change year over year.
Glaukos Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 34.54 M, a 100.32% change year over year.